The Home Spirometer a Father Couldn't Buy Became RemetricHealth's Remote-Care Business

The first RemetricHealth product did not emerge from a workshop about total addressable markets. It came from a father watching his daughter deal with severe, exercise-induced asthma. Wayne Meng knew what happened when they reached an emergency department: a clinician checked her lung function. What he could not find was a practical way to make the same measurement at home, where the uncertainty began.

Meng had a useful unfair advantage. He had started a medical-device manufacturing company in 1990 and understood how to turn an instrument into a regulated product. In 2010, the business then called PMD Healthcare introduced Spiro PD, a personal spirometer designed for patients to test lung function outside the clinic. The FDA cleared the diagnostic device in November 2011. It weighs about nine ounces, displays readings on a color screen, coaches the test with lights and sound, and sends results to a secure portal.

“What started out as a quest to fulfill a need in my family became a broader mission to help others.”Wayne Meng, founder and CEO

A device was the wedge, not the destination

Spiro PD answered one crisp question: what is happening to a patient's lung function right now? RemetricHealth gradually applied the same logic to other signals. Its current remote patient monitoring program covers blood pressure, heart rate, weight, blood oxygen, glucose, temperature, symptoms, medication use and whether a patient is taking readings as expected. The company markets programs for hypertension, heart failure, COPD, diabetes and respiratory care, among other chronic conditions.

The customers are not consumers browsing an app store. They are physician groups, hospitals, home health agencies, community health centers and payers. Those organizations need visibility between appointments, but they also have limited staff time. RemetricHealth's answer is a managed service: enroll and train the patient, ship and connect the device, collect readings, watch adherence, handle first-line support, surface exceptions, document the work and help the provider produce reimbursement reports.

That bundle explains where the company fits in digital health. It is part medical-device vendor, part software platform, part logistics operator and part outsourced clinical team. Calling it SaaS misses the blood-pressure cuffs and shipping. Calling it hardware misses the portal, apps and reporting. Calling it a staffing company misses the connected instruments. The awkward combination is the product.

What failed first: the blank shelf

The founding failure was simple: Meng looked for a home-use digital spirometer and could not find the option his family needed. Building one changed the available decision. Instead of judging every asthma episode from symptoms alone, a family and its care team could see a lung-function trend. The company's expansion suggests the next realization: a measurement is valuable only when it reaches someone who can interpret and act on it.

That is also where remote monitoring programs commonly wobble. A device sits unopened. A patient struggles with Wi-Fi. Readings stop after a week. A practice receives too many alerts. Nobody logs enough eligible time or keeps the documentation needed to bill. RemetricHealth explicitly sells around these failure modes. Its wireless devices can send data automatically, its multilingual staff can support patients, and its nurses can manage routine monitoring so clinicians see the cases that merit attention.

The service layer is the company's practical difference from a software-only competitor. A practice could assemble the pieces itself: buy connected devices, integrate data with its EHR, assign staff to onboarding, create escalation rules, call patients who disappear and track billing requirements. For a large organization with an experienced virtual-care team, that may be sensible. RemetricHealth is betting that many customers would rather buy the assembled loop.

The money is real, but it is not a price list

RemetricHealth does not publish its contract pricing. What it does publish is the reimbursement opportunity for eligible care. Its 2026 RPM page lists illustrative amounts from $21 for setup and education to monthly payments tied to device readings and monitoring time. The CCM page lists $63 for an initial 20 minutes of qualifying monthly service and $50 for an additional 20 minutes. These are provider reimbursement figures, not the company's fees, and actual payment varies by payer, geography, eligibility and current rules.

This matters because reimbursement is both an incentive and a constraint. A clinic cannot throw a cuff at a patient and collect recurring revenue. Eligibility, consent, device use, interactive communication, monitoring time, documentation and payer policy all matter. The managed-service model earns its keep when it makes those requirements operationally repeatable. It disappoints when the patient population, payer mix or clinical workflow cannot support them.

The human moat is pleasantly unglamorous

RemetricHealth's patient testimonials are revealing because they rarely celebrate a dashboard. Patients mention reminders, calls, texts, helpful nurses and the reassurance that somebody notices an unusual reading. One patient described daily figures helping a physician reduce a blood-pressure medication. Another praised the flexibility to communicate by phone, text or email. These are company-selected accounts, not controlled outcomes studies, but they show what users perceive as the service: attention.

The company says more than half of U.S. lung-transplant centers support its work and that it works with many pulmonary centers and advocacy groups. It has also built a distribution and education relationship with McKesson Medical-Surgical, whose catalog lists RemetricHealth monitors, scales, oximeters, glucose meters and an RPM kit. Industry education has included programming with the National Association of Community Health Centers and the Upper Midwest Telehealth Resource Center.

Recognition has been modest but relevant. MedHealth Outlook placed the company on its remote patient monitoring list in 2021 and again the following year. More useful than an award is the longevity: the business has spent more than a decade moving from a single respiratory instrument toward a broader chronic-care operation while keeping the original idea intact. Health changes between visits. Measure it there.

A small company in a crowded middle

The alternatives are plentiful. A buyer can choose a managed RPM specialist such as HealthSnap, Optimize.health, CoachCare, Prevounce or TimeDoc Health. A health system can buy an enterprise monitoring platform, contract for devices separately, or extend tools already embedded in its electronic health record. It can also hire nurses and build the operating model in-house. RemetricHealth's case is strongest when a customer wants one accountable partner across hardware, patient support, routine clinical work and the monthly paperwork.

That position produces a less glamorous sales pitch than artificial intelligence diagnosing disease from a distance. RemetricHealth mainly promises to make an existing model of care function with fewer dropped handoffs. Its expertise sits in medical-device manufacturing, respiratory measurement, connected-data workflows, patient engagement and the mechanics of reimbursable care. The public support center makes this visible. It has manuals for cuffs, scales, oximeters and Spiro PD alongside instructions for administrators setting alerts, providers logging activity and patients installing the mobile app. The details are the strategy.

The company remains private and small. Public company data supplied for this profile lists 18 employees, while LinkedIn places it in the 11-to-50 range. A supplied financing record shows $500,000 of debt financing in 2016; no public valuation or revenue figure is available. That scale makes the McKesson channel especially relevant. Distribution can put devices in front of practices without requiring RemetricHealth to build a huge direct-sales machine, while joint webinars and conference sessions explain the care and reimbursement model before the purchasing conversation begins.

Where the model bends

Remote monitoring is not continuous care by magic. It depends on a patient being willing and able to take measurements, a device maintaining connectivity, thresholds producing useful rather than noisy alerts, and a licensed care team having a clear path to intervene. It also depends on the provider remaining clinically responsible. RemetricHealth can operate much of the machinery, but it cannot make an unsuitable patient engaged or turn weak clinical governance into good care.

Nor will the managed approach win every procurement. Large health systems may prefer to build on an existing EHR and employ their own virtual nursing team. Small practices with too few eligible patients may not generate enough activity to justify a program. Organizations should compare total cost, device replacement, integration work, clinical coverage, patient retention, alert quality and realized reimbursement, not the shiniest product demonstration.

Still, RemetricHealth offers a durable product lesson. The company began with a tool that made one frightening family moment more legible. It expanded by noticing that the useful unit was not the reading but the completed loop around the reading. That loop is fiddly, regulated and full of phone calls. It is also where remote care becomes care.